Wednesday
SESSION 32: MORE ADVANCES IN MEDICAL TREATMENTS; MORE ABOUT NEW DRUGS; STEM CELL TREATMENTS; CATHETER BASED TREATMENTS FOR RESISTANT HYPERTENSION
Location: Grand Ballroom West, 3rd Floor
Moderators:Michael R. Jaff, DO / Kim J. Hodgson, MD  
SESSION 32 SCHEDULE
MORE ABOUT NEW DRUG TREATMENTS
7:47 AM - 7:52 AM New RCT Evidence Shows That An Omega 3 Fatty Acid Formula, Vascepa, Reduces By 25% Major Adverse Cardiac Events In Patients With High Triglycerides (The REDUCE-IT Trial): Bempedoic Acid Reduces LDL-C And C-Reactive Protein: Improved Best Medical Treatment Will Sharply Decrease The Need For Interventional Treatments
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC   
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:53 AM - 7:58 AM Optimal Use Of Direct Oral Anticoagulants (DOACs) After Open Bypasses And After Endovascular Procedures
  Presenter(s):Peter Henke, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:59 AM - 8:04 AM All Vascular Patients Should Be On Statins: What Drug, What Dose: It Matters: There Are Dire Penalties If Statins Are Stopped
  Presenter(s):Christos D. Liapis, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
UPDATE ON STEM CELL THERAPY
8:05 AM - 8:10 AM Does Stem Cell Therapy Have A Future In The Treatment Of Ischemic Vascular Disease
  Presenter(s):Dong-ik Kim, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:11 AM - 8:16 AM Update On The Value Of Autologous Stem Cell Therapy To Treat Lower Extremity Ischemia: Many Studies Indicate It Helps, But Not Much
  Presenter(s):Sigrid Nikol, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
ADVANCES IN CATHETER BASED TREATMENT OF RESISTANT HYPERTENSION
8:17 AM - 8:22 AM Current Status And Future Potential Of Endovascular Devices In The Treatment Of Resistant Hypertension: Does Renal Denervation Work
  Presenter(s):Sahil A. Parikh, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:23 AM - 8:28 AM Status Of RCTs And Other Trials Showing The Comparative Value Of Different Catheter Based Techniques For Renal Denervation For Alleviating Resistant Hypertension: Radiofrequency (Spyral Medtronic), Ultrasound Paradise Catheter (ReCor Medical), And Alcohol Infusion Into Renal Artery Adventitia (Peregrine Catheter, Ablative Solutions); They All Work
  Presenter(s):Horst Sievert, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:29 AM - 8:34 AM Value Of A Stent-Like Mobius HD Device (From Vascular Dynamics) To Reshape The Carotid Sinus, Amplify The Baroreflex And Lower Blood Pressure In Drug Resistant Hypertension
  Presenter(s):Gregg W. Stone, MD / Kim J. Hodgson, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:35 AM - 8:40 AM Update On Value Of ROX Coupler Device To Create An Iliac A-V Fistula And Control Blood Pressure In Resistant Hypertension: How It Works And Results Of A Sham Controlled RCT
  Presenter(s):David H. Deaton, MD, FACS / Krishna J. Rocha-Singh, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:41 AM - 8:46 AM Late Breaking Results Cast Doubt On The Katsanos Meta-Analysis: A Multicenter Study In 2071 Propensity Matched Patients (With CTLI And IC) Shows No Mortality Effect Of Paclitaxel Coated Devices 2 Years After Treatment
  Presenter(s):Hany Zayed, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:47 AM - 8:54 AM Panel Discussion
8:54 AM - 9:04 AM Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 32
previous next